Ventricular arrhythmias: When to worry

Pediatric Cardiology

Volumn 21, Issue 6, 2000, Pages 532-541

  Alexander, M E ^a,b   Berul, C I ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Congenital heart disease; Premature ventricular beats; Sudden death; Ventricular tachycardia

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; HEART DILATATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; LONG QT SYNDROME; MORTALITY; SYNCOPE;

ARRHYTHMIA; CARDIOMYOPATHIES; CHILD; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGY; HEART DEFECTS, CONGENITAL; HUMANS; PROGNOSIS; RISK FACTORS; VENTRICULAR PREMATURE COMPLEXES;

EID: 0033745647     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002460010131     Document Type: Article

References (112)

1. Value of programmed ventricular stimulation in patients with congenital heart disease
2. Idiopathic dilated cardiomyopathy in children: Prognostic indicators and outcome
3. QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot
4. Simultaneous AV nodal reentrant and ventricular tachycardia
5. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children
6. Provocative testing in children with suspect congenital long QT syndrome
7. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure
8. Long QT syndrome during high-dose cisapride
9. Cardiac septal hypertrophy in hyperinsulinemic infants
10. Sudden death and tetralogy of Fallot. Risks, markers, and causes
11. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease
12. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report
13. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death
14. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope
15. Ventricular arrhythmias in postoperative tetralogy of Fallot
16. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: A 12-year prospective study
17. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children
18. Ventricular tachycardia in a young population without overt heart disease
19. Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot
20. Ambulatory electrocardiographic monitoring in 100 healthy teenage boys
21. Life-threatening arrhythmias and RV dysfunction after surgical repair of tetralogy of Fallot. Comparison between transventricular and transatrial approaches
22. Sudden unexpected death in children and adolescents
23. Syncope in children and adolescents
24. Inducible ventricular arrhythmias in a naturally occurring model of cardiomyopathy
25. Implantable cardioverter defibrillators: Unique aspects in children and patients with congenital heart disease
26. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest
27. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations
28. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group
29. Myocardial mechanics before and after ablation of chronic tachycardia
30. Familial cardiomyopathy associated with right bundle branch block, ST segment elevation and sudden death
31. Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults
32. Clinical course of idiopathic dilated cardiomyopathy in children
33. Ambulatory monitoring of the sudden death of an adolescent with hypertrophic cardiomyopathy
34. Ventricular arrhythmias after repair of congenital heart disease: Who needs treatment?
35. GW3: The long QT syndrome in children. An international study of 287 patients
36. Induction of ventricular tachycardia during electrophysiologic study after repair of tetralogy of Fallot
37. Ventricular arrhythmias and sudden death in children
38. Incessant ventricular tachycardia in infants: Myocardial hamartomas and surgical cure
39. Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia?
40. Accelerated ventricular rhythm in childhood
41. Infantile histiocytoid cardiomyopathy - Myocardial or conduction system hamartoma: What is the cell type involved?
42. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease
43. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects. Council on Cardiovascular Disease in the Young, American Heart Association
44. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot
45. Proarrhythmia associated with cisapride in children
46. The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men
47. Unexpected cardiac arrest in patinets after surgical correction of tetralogy of Fallot
48. Should ICDs be implanted in all patients with dilated cardiomyopathy and unexplained syncope
49. Risk assessment of patients having congenital heart disease using electrophysiologic testing: Finally, opening the right door, or, an impossible chore
50. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy
51. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator
52. Predicting sudden death in patients who have undergone tetralogy of Fallot repair: Is it really as simple as measuring ECG intervals?
53. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients
54. Outcome of infants and children with dilated cardiomyopathy
55. Specificity of head-up tilt testing in adolescents: Effect of various degrees of tilt challenge in normal control subjects
56. Commotio cordis: Ventricular fibrillation, coronary vasospasm, myocardial contusion? Cardiovascular and electrophysiologic manifestations of a rare survivor
57. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults
58. Induction of sustained ventricular tachycardia after surgical repair of tetralogy of Fallot
59. The molecular genetics of hypertrophic cardiomyopathy
60. Right ventricular overload and induced sustained ventricular tachycardia in operatively 'repaired' tetralogy of Fallot
61. Sudden death in young athletes. Lessons from the Hank Gathers affair
62. Triggers for sudden cardiac death in the athlete
63. Clinical profile of commotio cordis: An under appreciated cause of sudden death in the young during sports and other activities
64. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy
65. Risk for sudden cardiac death associated with marathon running
66. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
67. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
68. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation
69. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis
70. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy
71. Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone
72. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome
73. The long QT syndrome. Prospective longitudinal study of 328 families
74. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy
75. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot
76. Cardiac arrhythmias in healthy children revealed by 24-hour ambulatory ECG monitoring
77. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential
78. Sudden and unexpected natural death in childhood and adolescence
79. Hypertrophic cardiomyopathy in Noonan syndrome
80. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair
81. Radiofrequency catheter ablation of right ventricular outflow tachycardia in children and adolescents
82. Long-term outcome of verapamil-sensitive sustained left ventricular tachycardia in patients without structural heart disease
83. Ventricular couplets in the young: Prognosis related to underlying substrate
84. Ventricular tachycardia and ventricular fibrillation in a young population
85. Athlete's heart in women. Echocardiographic characterization of highly trained elite female atheletes
86. Idiopathic ventricular tachycardia in infancy and childhood
87. Ventricular tachycardia in children
88. Radiofrequency catheter ablation of idiopathic ventricular tachycardia originating in the anterior fascicle of the left bundle branch
89. Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia
90. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings
91. Sudden death in an infant due to histiocytoid cardiomyopathy. A light-microscopic, ultrastructural, and immunohistochemical study
92. Syncope associated with exercise, a manifestation of neurally mediated syncope
93. Preventing sudden death after repair of tetralogy of Fallot: Complex therapy for complex patients
94. Results of 24 hour ambulatory monitoring of electrocardiogram in 131 healthy boys aged 10 to 13 years
95. Radiofrequency catheter ablation for idiopathic right ventricular tachycardia: First, last or only therapy - Who decides?
96. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger
97. Arrhythmias documented by 24-hour continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease
98. Prospective study of fetal heart rate and rhythm patterns
99. Study of cardiac rhythm in healthy newborn infants
100. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia [see Comments]
101. Sudden death in a patient with apparent idiopathic ventricular tachycardia
102. Long-term follow-up of idiopathic ventricular arrhythmias in otherwise normal children
103. Ventricular tachycardia and accelerated ventricular rhythm presenting in the first month of life
104. Serial follow-up of adults with repaired tetralogy of Fallot
105. Late results in patients with tetralogy of Fallot repaired during infancy
106. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
107. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring
108. Myocardial bridging in children with hypertrophic cardiomyopathy - A risk factor for sudden death
109. Congenital 'histiocytoid' cardiomyopathy: Evidence suggesting a developmental disorder of the Purkinje cell system of the heart
110. Atrial induction of ventricular tachycardia: Reentry versus triggered automaticity
111. 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: Arrhythmias
112. Sudden cardiac death